Your browser doesn't support javascript.
loading
A case report of treatment of a streptococcal brain abscess with ceftobiprole supported by the measurement of drug levels in the cerebrospinal fluid.
Giuliano, Simone; Angelini, Jacopo; Flammini, Sarah; Della Siega, Paola; Vania, Eleonora; Montanari, Luca; D'Elia, Denise; Biasizzo, Jessica; Pagotto, Alberto; Tascini, Carlo.
  • Giuliano S; Infectious Diseases Division, Department of Medicine, University Hospital Friuli Centrale ASUFC, Udine, Italy.
  • Angelini J; Clinical Pharmacology and Toxicology Institute, University Hospital Friuli Centrale ASUFC, 33100, Udine, Italy.
  • Flammini S; Department of Medicine (DIME), University of Udine, Udine, Italy.
  • Della Siega P; Infectious Diseases Division, Department of Medicine, University Hospital Friuli Centrale ASUFC, Udine, Italy.
  • Vania E; Infectious Diseases Division, Department of Medicine, University Hospital Friuli Centrale ASUFC, Udine, Italy.
  • Montanari L; Infectious Diseases Division, Department of Medicine, University Hospital Friuli Centrale ASUFC, Udine, Italy.
  • D'Elia D; Infectious Diseases Division, Department of Medicine, University Hospital Friuli Centrale ASUFC, Udine, Italy.
  • Biasizzo J; Infectious Diseases Division, Department of Medicine, University Hospital Friuli Centrale ASUFC, Udine, Italy.
  • Pagotto A; Clinical Pathology Division, Department of Laboratory Medicine, University Hospital Friuli Centrale ASUFC, Udine, Italy.
  • Tascini C; Infectious Diseases Division, Department of Medicine, University Hospital Friuli Centrale ASUFC, Udine, Italy.
Heliyon ; 10(6): e27285, 2024 Mar 30.
Article en En | MEDLINE | ID: mdl-38515704
ABSTRACT
In this paper, we describe the case of a patient admitted to our hospital because of a brain abscess due to Streptococcus intermedius. The management of brain abscess is challenging given the limited potential drug options with effective penetration into both the central nervous system and the abscess capsule to achieve adequate therapeutic concentrations. Due to the high anti-streptococcal activity of ceftobiprole and the availability of ceftobiprole therapeutic drug monitoring in our hospital, we decided to treat the patient with ceftobiprole. To maximize the antimicrobial effect of ceftobiprole, we chose a prolonged intravenous infusion, and we monitored its concentrations in both plasma and cerebrospinal fluid.
Palabras clave